Nadia Mores Selected Research

Nitroprusside (Sodium Nitroprusside)

1/2018	Favorable Vascular Actions of Angiotensin-(1-7) in Human Obesity.
1/2017	Beneficial Effects of Apelin on Vascular Function in Patients With Central Obesity.
12/2010	Generalized impairment of vasodilator reactivity during hyperinsulinemia in patients with obesity-related metabolic syndrome.
11/2009	Ghrelin restores the endothelin 1/nitric oxide balance in patients with obesity-related metabolic syndrome.
7/2008	Tumor necrosis factor-alpha antagonism improves vasodilation during hyperinsulinemia in metabolic syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nadia Mores Research Topics

Disease

8	Chronic Obstructive Pulmonary Disease (COPD) 01/2020 - 03/2013
8	Inflammation (Inflammations) 01/2018 - 09/2006
7	Obesity 01/2018 - 07/2008
7	Hyperinsulinism (Hyperinsulinemia) 01/2018 - 05/2004
7	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2015 - 07/2008
4	Asthma (Bronchial Asthma) 03/2017 - 08/2014
3	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2016 - 01/2013
1	COVID-19 10/2021
1	Epistaxis (Nosebleed) 11/2020
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2020
1	Progressive Multifocal Leukoencephalopathy 01/2020
1	Body Weight (Weight, Body) 01/2018
1	Cystic Fibrosis (Mucoviscidosis) 01/2018
1	Insulin Resistance 01/2017
1	Abdominal Obesity 01/2017
1	Eosinophilia 11/2016
1	Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome 11/2016
1	Purpura 06/2016
1	Vasculitis (Vasculitides) 06/2016
1	Mumps 06/2016
1	Measles 06/2016
1	Rubella (German Measles) 06/2016
1	Allergic Rhinitis 06/2016
1	Metabolically Benign Obesity 11/2015
1	Human Influenza (Influenza) 07/2014
1	Drug-Related Side Effects and Adverse Reactions 04/2014

Drug/Important Bio-Agent (IBA)

9	Vasodilator Agents (Vasodilators)IBA 01/2017 - 05/2004
6	Pharmaceutical PreparationsIBA 01/2018 - 01/2013
5	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 01/2018 - 07/2008
5	Insulin (Novolin)FDA Link 01/2017 - 05/2004
4	Formoterol Fumarate (Oxis)FDA Link 01/2020 - 11/2016
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2013
4	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2018 - 07/2008
4	Ascorbic Acid (Vitamin C)FDA LinkGeneric 03/2013 - 07/2008
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 11/2016
3	Beclomethasone (Beclometasone)FDA Link 01/2020 - 11/2016
3	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2018 - 11/2016
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017 - 11/2009
3	Endothelin-1 (Endothelin 1)IBA 01/2017 - 11/2009
3	VaccinesIBA 06/2016 - 01/2013
3	Endothelins (Endothelin)IBA 11/2015 - 11/2009
2	Fluticasone-Salmeterol Drug Combination (Advair)FDA Link 01/2020 - 01/2018
2	SuspensionsIBA 01/2020 - 01/2018
2	fluticasone furoate FDA Link 01/2018 - 11/2016
2	8-epi-prostaglandin F2alphaIBA 01/2018 - 01/2016
2	vilanterolIBA 01/2018 - 11/2016
2	GSK573719IBA 01/2018 - 11/2016
2	Dinoprostone (PGE2)FDA Link 01/2018 - 01/2016
2	GhrelinIBA 01/2017 - 11/2009
2	Vasoconstrictor AgentsIBA 01/2017 - 11/2009
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 03/2013
2	cyclo(Trp-Asp-Pro-Val-Leu)IBA 03/2013 - 11/2009
2	omega-N-Methylarginine (NG Monomethyl L Arginine)IBA 03/2013 - 11/2009
2	Nitric Oxide Synthase (NO Synthase)IBA 03/2013 - 11/2009
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2008 - 09/2006
1	BNT162 VaccineIBA 10/2021
1	bromfenacoum (Ratak)IBA 11/2020
1	Rituximab (Mabthera)FDA Link 01/2020
1	Bendamustine Hydrochloride FDA Link 01/2020
1	Nitrogen DioxideIBA 01/2020
1	SteroidsIBA 01/2020
1	Vitamin E FDA LinkGeneric 01/2018
1	Bronchodilator Agents (Bronchodilators)IBA 01/2018
1	aclidinium bromideIBA 01/2018
1	Acetates (Acetic Acid Esters)FDA Link 01/2018
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2018
1	angiotensin I (1-7)IBA 01/2018
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 03/2017
1	mepolizumabIBA 03/2017
1	Monoclonal AntibodiesIBA 03/2017
1	reslizumabIBA 03/2017
1	Interleukin-13IBA 03/2017
1	Omalizumab (Xolair)FDA Link 03/2017
1	Interleukin-4 (Interleukin 4)IBA 03/2017
1	dupilumabIBA 03/2017
1	AngiotensinsIBA 01/2017
1	ApelinIBA 01/2017
1	Budesonide (Pulmicort)FDA LinkGeneric 11/2016
1	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 11/2016
1	Measles-Mumps-Rubella Vaccine (MMR Vaccine)IBA 06/2016
1	prostaglandin D2 receptorIBA 06/2016
1	asapiprantIBA 06/2016
1	Leukotriene C4IBA 08/2014
1	Leukotriene D4IBA 08/2014
1	LeukotrienesIBA 08/2014
1	Leukotriene B4IBA 08/2014
1	Biological ProductsIBA 08/2014
1	LipidsIBA 08/2014
1	Leukotriene E4IBA 08/2014
1	Influenza Vaccines (Influenza Vaccine)FDA Link 07/2014
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 04/2014
1	LeptinIBA 03/2013
1	Arginine (L-Arginine)FDA Link 03/2013
1	glucagon-like peptide-1 (9-36)IBA 03/2013

Therapy/Procedure

4	Therapeutics 01/2020 - 11/2016
3	Electronic Nose 01/2016 - 01/2013
3	Intra-Arterial Infusions 12/2010 - 07/2008
2	Nebulizers and Vaporizers (Inhaler) 01/2018 - 01/2018
1	Drug Therapy (Chemotherapy) 01/2020
1	Aftercare (After-Treatment) 01/2018